Edited By: Chiara Romagnani (Chair of the Executive Committee)
The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more.
Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.
Highlights
Articles
Highly sensitive reporter cell line for detection of interferon types I–III and their neutralization by antibodies
-  4 October 2024
Graphical Abstract
Interferons (IFNs) are a critical component of innate immune defenses and limit viral disease severity. To advance studies on IFNs and their neutralization by pathogenic autoantibodies, we generated a Renilla luciferase-based reporter cell line capable of detecting the activities of IFN-Is, IFN-II, and IFN-IIIs. The reporter cell line exhibits a 125- to 2000-fold higher sensitivity to IFNs than a commonly used alternative biological reporter system and allows for a rapid and simple live-cell workflow for detecting low titer amounts of neutralizing anti-IFN antibodies.
Cover Story: Eur. J. Immunol. 10'24
-  4 October 2024
Graphical Abstract
Our cover features images related to flow cytometry techniques widely used for analysis of function and phenotypes of major human and murine immune cell subsets, superimposed on a multidimensional immune cell population scatter plot. These images are taken from the third edition of EJI's Flow Cytometry Guidelines by Cossarizza et al., a comprehensive resource prepared by flow cytometry and immunology research experts from around the world.
A20 intrinsically influences human effector T‐cell survival and function by regulating both NF‐κB and JNK signaling
-  2 October 2024
Graphical Abstract
The ubiquitin-editing enzyme A20 regulates innate and adaptive immune receptor signaling, but its intrinsic function in human T cells is poorly understood. We show that A20 deletion enhances cytokine secretion and alters apoptosis sensitivity in primary human T cells by modulating NF-kB and JNK/AP-1 signaling downstream of the CARD11-BCL10-MALT1 complex.
Liver type 1 innate lymphoid cells undergo apoptosis in murine models of macrophage activation syndrome and are dispensable for disease
-  30 September 2024
Graphical Abstract
In macrophage activation syndrome, a severe cytokine storm syndrome with liver inflammation, liver type 1 innate lymphoid cells (ILC1s) rapidly produce proinflammatory cytokines. However, disease progression results in liver ILC1 apoptosis. In addition, disease development was unaltered in Hobit knockout mice, which lack liver ILC1s, indicating their dispensability for disease.
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Nanoparticles target distinct dendritic cell populations according to their size
-  1404-1413
-  18 April 2008
Targeting Treg cells in cancer immunotherapy
-  1140-1146
-  30 June 2019
Graphical Abstract
Regulatory T (Treg) cells highly infiltrate into various tumor tissues and hinder immune responses against tumor cells by effector T (Teff) cells. To effectively enhance anti-tumor immunity, it is essential to selectively remove tumor-infiltrating Treg cells while preserving tumor-reactive Teff cells.
The who's who of T-cell differentiation: Human memory T-cell subsets
-  2797-2809
-  30 October 2013
CD69: from activation marker to metabolic gatekeeper
- European Journal of Immunology
-  946-953
-  5 May 2017
IL‐6: Regulator of Treg/Th17 balance
- European Journal of Immunology
-  1830-1835
-  25 June 2010
Recent issues
- Volume 54, Issue 10October 2024
- Volume 54, Issue 9September 2024